AUSTIN, Texas, Feb. 15, 2024 /PRNewswire/ — eHealth, Inc. (Nasdaq: EHTH), a leading private online health insurance marketplace, today announced that the company plans to release fourth quarter and fiscal year 2023 financial results on February 27, 2024.
The company will hold an earnings conference call beginning at 8:30 a.m. Eastern Time on February 27th to discuss these results. The call will be hosted by eHealth’s chief executive officer, Fran Soistman and eHealth’s chief financial officer, John Stelben.
Individuals interested in listening to the conference call may do so by dialing (800) 225-9448. The participant passcode is 4737247.
A live webcast of the earnings call will be available under “News and Events” on the Investor Relations page of our website at https://ir.ehealthinsurance.com. The webcast replay will also be available on our investor relations website two hours following the conclusion of the call and will be archived for a period of one year. The company suggests participants for both the conference call and those listening via the web dial in or sign on at least 15 minutes in advance of the call.
About eHealth, Inc.
We’re Matchmakers. For over 25 years, eHealth has helped millions of Americans find the healthcare coverage that fits their needs at a price they can afford. Consumers can visit our health insurance marketplace at eHealth.com, or call us to speak with a licensed insurance agent at 1-833-964-1202. As a leading independent licensed insurance agency and advisor, eHealth offers access to over 180 health insurers, including national and regional companies.
For more information, visit eHealth.com or follow us on LinkedIn, Facebook, Instagram, and X. Open positions can be found on our career page.
Investor Relations Contact:
Kate Sidorovich, CFA
Senior Vice President, Investor Relations & Strategy
investors@ehealth.com
http://ir.ehealthinsurance.com
SOURCE eHealth, Inc.
Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at…
LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…
Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…
Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…
Independent analysis examines why 'natural Ozempic alternative' and 'berberine weight loss patch' searches are driving…